Helixism Biomedical Inc.
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
The ECP (External Counterpulsation) therapy device is a non-invasive solution and system platform for the treatment and prevention of cardiovascular diseases. Helixism Biomedical Inc.’s patented technology redefines efficiency in pressure management, achieving the same therapeutic results within an extremely compact design. As the only highly efficient, fully featured system operating on a 110V power supply, its lightweight design significantly enhances installation flexibility for medical institutions. Featuring an ergonomic design with a minimum height of just 48 cm from the ground, it allows patients to easily get on and off the machine, providing enhanced safety and security. The system generates minimal physical vibration and noise during operation, greatly improving the patient's treatment experience. The user-friendly operating interface shortens the learning curve for medical staff. Independently developed and manufactured with proprietary Taiwanese technology, this system has won the 17th National Innovation Award and holds patents in multiple countries and regions, including Taiwan, the United States, Japan, the United Kingdom, and the European Union.
The content above was translated by Ai
Founded Year
2021
Unified Business No.
91077301
Status
Active
Number of Employees
10
Total Paid-in
Capital
29,999,500 (NT$)
Location of Company
Taiwan
, New Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Helixism Biomedical Inc. is a startup company established in 2021, located in the Farglory U-Town office and factory building in Xizhi. Given that ischemic heart disease and stroke have been the leading causes among the world's top ten causes of death for 20 consecutive years, and that the elderly and obese populations are rapidly increasing, our company is dedicated to providing non-invasive solutions and system platforms for the treatment and prevention of cardiovascular diseases, thereby enhancing the well-being of healthy living for all humanity.
Furthermore, in addition to strengthening technological innovation, manufacturing speed, quality, flexibility, and cost reduction to establish a unique proprietary brand, the company will elevate to global platform logistics and corporate resource integration in the future. We will not only continue to take root in cardiovascular-related medical and preventive medicine industries, but also commit to global deployment to create the overall value of the company and the team.
Furthermore, in addition to strengthening technological innovation, manufacturing speed, quality, flexibility, and cost reduction to establish a unique proprietary brand, the company will elevate to global platform logistics and corporate resource integration in the future. We will not only continue to take root in cardiovascular-related medical and preventive medicine industries, but also commit to global deployment to create the overall value of the company and the team.
The content above was translated by Ai
